TMCI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Treace Medical Concepts Inc (TMCI) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock is currently in a bearish technical trend, has mixed analyst sentiment, and lacks significant positive catalysts. While the company has potential for recovery, the current financial performance and market sentiment do not align with a strong long-term investment opportunity.
The stock is in a bearish trend with MACD below zero and negatively expanding, RSI indicating oversold conditions at 16.237, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.416 and 1.207, with resistance levels at 2.092 and 2.301.
RSI indicates oversold conditions, which could suggest a potential rebound in the short term. Analysts see little downside risk for patient investors.
Analysts have lowered price targets, and there is no recent significant insider or congress trading activity to indicate confidence.
In Q4 2025, revenue dropped by 9.01% YoY to $62.5 million. Net income improved but remains negative at -$9.4 million. EPS increased to -$0.15, and gross margin slightly declined to 80.62%.
Analysts have mixed ratings. Lake Street maintains a Buy rating with a price target of $7 but highlights a mixed 2026 outlook. UBS and Truist have lowered price targets to $2.25 and $2, respectively, with neutral or hold ratings.
